Lilly halts Alzheimer's drug trial due to liver problems
By Ransdell Pierson (Reuters) - Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's diseas...
Read More »By Ransdell Pierson (Reuters) - Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's diseas...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Teenage mothers are at increased risk of delivering their babies prematurely, while ...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Cross-country skiers who have completed more races at faster speeds have a higher ri...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - For people with existing heart problems, exposure to high levels of air pollution can t...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Although doctors sometimes prescribe anti-seizure drugs to treat chronic pain in the vulv...
Read More »
By Lawrence Hurley WASHINGTON (Reuters) - A unanimous U.S. Supreme Court on Thursday prohibited patents on naturally occurring human...
Read More »
By Constance Watson LONDON (Reuters) - Forget abandoning carbohydrates or detoxing. The new dieting craze sweeping Britain and takin...
Read More »(Reuters) - Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with...
Read More »
By Kate Kelland and Ben Hirschler LONDON (Reuters) - Puffing on slim metal tubes loaded with pale yellow liquid, two London business...
Read More »
By Kate Kelland LONDON (Reuters) - Austerity cuts in Spain could lead to the effective dismantling of large parts of its healthcare ...
Read More »